Tradestie Institutional Equity Comparison Engine

ZLAB vs VKTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZLAB Overall Edge

ZLAB Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Zai Lab Limited American Depositary Shares (ZLAB) driven by superior Momentum & Technical, Options & Structure while VKTX counters with relative strength in Growth & Margin. Fundamentally, ZLAB trades at N/M Forward P/E with -63.0% operating margin (-6.8% YoY revenue) versus VKTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro) against VKTX sits in BREAKDOWN (88th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ZLAB N/M vs VKTX N/M Fwd P/E
Growth & Margin Winner VKTX
Op Margin -63.0% vs 0.0% ยท YoY -6.8% vs +0.0%
Momentum & Technical Winner ZLAB
1Y +9.7% vs -31.1% ยท 52W Pos 60% vs 16%
Options & Structure Winner ZLAB
UNCLASSIFIED (58th %ile IV) vs BREAKDOWN (88th %ile IV)
ZLAB NASDAQ
Zai Lab Limited American Depositary Shares
Pharmaceutical Preparations
$23.83
-3.13% 1D
Market Cap $3.0B
1M Return +2.76%
1Y Return +9.66%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 53.5
VKTX NASDAQ
Viking Therapeutics, Inc
Pharmaceutical Preparations
$26.86
-8.08% 1D
Market Cap $3.8B
1M Return +6.71%
1Y Return -31.13%
Forward P/E N/M
Unified AI Score
46.5 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 71.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZLAB +9.66% VKTX -31.13% Spread: +40.79 pp (ZLAB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZLAB TTM Op. Margin: -63.0% VKTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZLAB vs VKTX. Trailing 12-month operating profitability (ZLAB -63.0% vs VKTX 0.0%) and valuation multiples (ZLAB N/M vs VKTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZLAB (3) vs VKTX (5)
Institutional Metric ZLAB VKTX Criterion Row Winner
Market Capitalization Scale $3.0B $3.8B Larger Scale VKTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -6.8% +0.0% Higher Growth VKTX
Operating Margin (TTM) Profitability -63.0% 0.0% Higher Margin VKTX
Net Profit Margin Profitability -44.9% 0.0% Higher Margin VKTX
Return on Equity (ROE) Capital Efficiency -30.0% -96.4% Higher ROE ZLAB
52-Week Range Position Momentum 60% ($16โ€“$29) 16% ($24โ€“$43) Stronger Trend ZLAB
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 78% Vol 1.52ฮฒ ยท 74% Vol Lower Realized Risk VKTX
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 46.5 / 100 (HOLD) Higher Composite ZLAB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZLAB vs VKTX Buy Guide
ZLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ZLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VKTX BREAKDOWN
93d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 88th %ile
IV Regime Extreme (>80th %ile)
Live VKTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZLAB nor VKTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.